中华老年多器官疾病杂志
中華老年多器官疾病雜誌
중화노년다기관질병잡지
CHINESE JOURNAL OF MULTIPLE ORGAN DISEASES IN THE ELDERLY
2013年
8期
602-606
,共5页
王玲燕%章淬%郑曙云%李静%施乾坤%牛永胜%宋晓春%穆心苇
王玲燕%章淬%鄭曙雲%李靜%施乾坤%牛永勝%宋曉春%穆心葦
왕령연%장쉬%정서운%리정%시건곤%우영성%송효춘%목심위
左西孟旦%肾上腺素%心脏手术%低心排综合征
左西孟旦%腎上腺素%心髒手術%低心排綜閤徵
좌서맹단%신상선소%심장수술%저심배종합정
levosimendan%epinephrine%cardiac surgery%low cardiac output syndrome
目的比较左西孟旦和肾上腺素对心脏术后低心排综合征(LCOS)的作用。方法将48例心脏术后LCOS患者随机分为两组,左西孟旦组(A组,n=23)按0.05~0.2μg/(kg·min)持续24h,肾上腺素组(B组,n=25)按0.01~0.04μg/(kg·min)持续1周,维持平均动脉压≥65mmHg。监测心率、平均动脉压、肺毛细血管楔压、中心静脉压、心输出量、心指数、全身血管阻力;用心脏超声分别评价用药前和用药后3和7d的心功能;监测用药前和用药后24和48h的血乳酸值、血肌酐、尿素氮、尿量。观察术后并发症及预后情况。结果两种药物均能显著增加心输出量和心指数(P<0.05)。A组用药后各时间点全身血管阻力均较B组明显下降(P<0.05),且均较用药前明显下降(P<0.05)。A组用药后24,48h平均动脉压与用药前相比均有显著下降(P<0.05)。心脏超声结果显示两种药均能改善心功能(P<0.05)。用药后血乳酸值均显著降低(P<0.05)。A组用药后48h,尿素氮、血肌酐及尿量均较用药前变化显著(P<0.05),且该时间点尿素氮较B组显著降低(P<0.05)。与B组相比,A组房颤发生率显著减少(P<0.05),术后并发症也有减少的趋势。结论两种药物均能明显提高心脏术后LCOS患者血流动力学及心功能指标,改善组织灌注,而左西孟旦对患者肾功能更有益。
目的比較左西孟旦和腎上腺素對心髒術後低心排綜閤徵(LCOS)的作用。方法將48例心髒術後LCOS患者隨機分為兩組,左西孟旦組(A組,n=23)按0.05~0.2μg/(kg·min)持續24h,腎上腺素組(B組,n=25)按0.01~0.04μg/(kg·min)持續1週,維持平均動脈壓≥65mmHg。鑑測心率、平均動脈壓、肺毛細血管楔壓、中心靜脈壓、心輸齣量、心指數、全身血管阻力;用心髒超聲分彆評價用藥前和用藥後3和7d的心功能;鑑測用藥前和用藥後24和48h的血乳痠值、血肌酐、尿素氮、尿量。觀察術後併髮癥及預後情況。結果兩種藥物均能顯著增加心輸齣量和心指數(P<0.05)。A組用藥後各時間點全身血管阻力均較B組明顯下降(P<0.05),且均較用藥前明顯下降(P<0.05)。A組用藥後24,48h平均動脈壓與用藥前相比均有顯著下降(P<0.05)。心髒超聲結果顯示兩種藥均能改善心功能(P<0.05)。用藥後血乳痠值均顯著降低(P<0.05)。A組用藥後48h,尿素氮、血肌酐及尿量均較用藥前變化顯著(P<0.05),且該時間點尿素氮較B組顯著降低(P<0.05)。與B組相比,A組房顫髮生率顯著減少(P<0.05),術後併髮癥也有減少的趨勢。結論兩種藥物均能明顯提高心髒術後LCOS患者血流動力學及心功能指標,改善組織灌註,而左西孟旦對患者腎功能更有益。
목적비교좌서맹단화신상선소대심장술후저심배종합정(LCOS)적작용。방법장48례심장술후LCOS환자수궤분위량조,좌서맹단조(A조,n=23)안0.05~0.2μg/(kg·min)지속24h,신상선소조(B조,n=25)안0.01~0.04μg/(kg·min)지속1주,유지평균동맥압≥65mmHg。감측심솔、평균동맥압、폐모세혈관설압、중심정맥압、심수출량、심지수、전신혈관조력;용심장초성분별평개용약전화용약후3화7d적심공능;감측용약전화용약후24화48h적혈유산치、혈기항、뇨소담、뇨량。관찰술후병발증급예후정황。결과량충약물균능현저증가심수출량화심지수(P<0.05)。A조용약후각시간점전신혈관조력균교B조명현하강(P<0.05),차균교용약전명현하강(P<0.05)。A조용약후24,48h평균동맥압여용약전상비균유현저하강(P<0.05)。심장초성결과현시량충약균능개선심공능(P<0.05)。용약후혈유산치균현저강저(P<0.05)。A조용약후48h,뇨소담、혈기항급뇨량균교용약전변화현저(P<0.05),차해시간점뇨소담교B조현저강저(P<0.05)。여B조상비,A조방전발생솔현저감소(P<0.05),술후병발증야유감소적추세。결론량충약물균능명현제고심장술후LCOS환자혈류동역학급심공능지표,개선조직관주,이좌서맹단대환자신공능경유익。
Objective To compare the effects of levosimendan vs epinephrine on low cardiac output syndrome (LCOS) after cardiac surgery. Methods Forty-eight patients with LCOS after cardiac surgery in our department from 2011 to 2012 were enrolled in this prospective study. They were randomly assigned to levosimendan group [n=23, 0.05 to 0.2μg·(kg·min) for 24h] and epinephrine group [n=25, 0.01 to 0.04μg·(kg·min) for 1 week] to maintain the mean arterial pressure ≥65mmHg. Their heart rate, mean arterial pressure, pulmonary artery wedge pressure, central venous pressure, cardiac output, cardiac index, systemic vascular resistance and cardiac function (evaluated by echocardiography before and on 3 and 7d after drug injection, respectively) were monitored as well as blood lactate and kidney function (urea nitrogen, serum creatinine and urine output before and at 24 and 48h after drug injection, respectively). The postoperative complications and prognosis were also observed. Results Cardiac output and cardiac index were significantly increased, but blood lactate was obviously decreased after the drug injection compared with before the injection (P<0.05). Levosimendan injection for 48h resulted in significant changes in urea nitrogen, serum creatinine and urine output (P<0.05), with the first one significantly lower than that of epinephrine group (P<0.05). There was significantly lower incidence of atrial fibrillation in levosimendan group than in epinephrine group (P<0.05). Levosimendan injection also caused a decreasing trend of post-operative complications. Conclusion Both leosimendan and adrenaline obviously improve the hemodynamic indices and cardiac functions, and tissue perfusion in LCOS patients after cardiac surgery. Leosimendan is more beneficial to renal function.